At this pace late July/August remains correct for topline results. Whatever their results, the true question with IPIX is how do they leverage their results...that's been a wee bit of a problem for the last 14 years.
I would like an update on:
+Alfasigma partnership (is it still alive); are they getting any money from them?
+GI Oral Trial (is this still happening / when?)
+COVID "Further Lab Testing" (they said they were doing this 3.5 months ago; why have they not shared results?)
+Partnerships (any?)
+Locust Walk (what's the status of their relationship?)
+ Kevetrin (what's the plan for this asset?)
+ Oral Mucositis (any partnerships? / what's the plan for their Phase 3 trial?)